| Dr Daniel Edward Murray Jr, OD | |
|
550 John D Odom Rd, Dothan, AL 36303-9461 | |
| (334) 699-5999 | |
| (334) 479-0631 |
| Full Name | Dr Daniel Edward Murray Jr |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 26 Years |
| Location | 550 John D Odom Rd, Dothan, Alabama |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477545770 | NPI | - | NPPES |
| 51044874 | Other | AL | BLUE CROSS BLUE SHIELD |
| 000044874 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S900TA450 (Alabama) | Primary |
| Provider Name | Southern Eye Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770591380 PECOS PAC ID: 9931292810 Enrollment ID: O20070908000134 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
Reconfigured body after reconfigured body, the hands of Alexander Moya, M.D., Director of the Center for Weight Loss Body Contouring and Assistant Director of the Geisinger Center for Aesthetics and Cosmetic Surgery at Geisinger Medical Center (GMC), skillfully addresses the excess skin his patients contend with following the loss of dozens, if not often hundreds, of pounds. According to Dr. Moya, it's this final therapeutic step of removing this skin and reshaping their bodies that often puts weight-loss patients at peace with themselves and what they see in the mirror every morning.
Today's headlines note the celebrations surrounding President Obama's signature of the Senate's health reform bill - making it the law of the land - and the strategies being developed by health overhaul opponents to block progress with an accompanying "fix it" bill.
Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported preliminary operating results for the second quarter ended July 4, 2010. A conference call to discuss these preliminary results will be held on July 21, 2010 at 9:00 a.m., Eastern Time. The Company will issue its final 2010 second quarter and six months financial results on July 29, 2010.
› Verified 6 days ago
| Provider Name | Murray Vision Source Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013226471 PECOS PAC ID: 3375722176 Enrollment ID: O20110302000798 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
Reconfigured body after reconfigured body, the hands of Alexander Moya, M.D., Director of the Center for Weight Loss Body Contouring and Assistant Director of the Geisinger Center for Aesthetics and Cosmetic Surgery at Geisinger Medical Center (GMC), skillfully addresses the excess skin his patients contend with following the loss of dozens, if not often hundreds, of pounds. According to Dr. Moya, it's this final therapeutic step of removing this skin and reshaping their bodies that often puts weight-loss patients at peace with themselves and what they see in the mirror every morning.
Today's headlines note the celebrations surrounding President Obama's signature of the Senate's health reform bill - making it the law of the land - and the strategies being developed by health overhaul opponents to block progress with an accompanying "fix it" bill.
Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported preliminary operating results for the second quarter ended July 4, 2010. A conference call to discuss these preliminary results will be held on July 21, 2010 at 9:00 a.m., Eastern Time. The Company will issue its final 2010 second quarter and six months financial results on July 29, 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Edward Murray Jr, OD 550 John D Odom Rd, Dothan, AL 36303-9461 Ph: (334) 699-5999 | Dr Daniel Edward Murray Jr, OD 550 John D Odom Rd, Dothan, AL 36303-9461 Ph: (334) 699-5999 |
News Archive
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
Reconfigured body after reconfigured body, the hands of Alexander Moya, M.D., Director of the Center for Weight Loss Body Contouring and Assistant Director of the Geisinger Center for Aesthetics and Cosmetic Surgery at Geisinger Medical Center (GMC), skillfully addresses the excess skin his patients contend with following the loss of dozens, if not often hundreds, of pounds. According to Dr. Moya, it's this final therapeutic step of removing this skin and reshaping their bodies that often puts weight-loss patients at peace with themselves and what they see in the mirror every morning.
Today's headlines note the celebrations surrounding President Obama's signature of the Senate's health reform bill - making it the law of the land - and the strategies being developed by health overhaul opponents to block progress with an accompanying "fix it" bill.
Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported preliminary operating results for the second quarter ended July 4, 2010. A conference call to discuss these preliminary results will be held on July 21, 2010 at 9:00 a.m., Eastern Time. The Company will issue its final 2010 second quarter and six months financial results on July 29, 2010.
› Verified 6 days ago
Murray Vision Source Inc Optometrist Medicare: Medicare Enrolled Practice Location: 550 John D Odom Rd, Dothan, AL 36303 Phone: 334-699-5999 Fax: 334-479-0631 | |
Dr. Michael Joel Hill, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4310 Montgomery Hwy, Dothan, AL 36303 Phone: 334-671-9719 Fax: 334-671-9721 | |
Jordan Johnson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-792-2211 | |
Dr. William H Feagin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 111 W Main St, Dothan, AL 36301 Phone: 334-794-1175 Fax: 334-793-0619 | |
Mr. David Walker Badham, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 151 W Main St, Dothan, AL 36301 Phone: 334-793-2633 Fax: 334-794-1626 | |
Dr. Lauren Elise Albert, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Medical Care Way, Dothan, AL 36303 Phone: 334-794-8797 Fax: 334-479-0658 | |
Paul Curtis Roten, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1936 Ross Clark Cir, Dothan, AL 36301 Phone: 334-794-0585 Fax: 337-671-4943 |